SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Alembic Pharmaceuticals gets EIR from USFDA for Karakhadi facility

08 Jul 2016 Evaluate

Alembic Pharmaceuticals has received Establishment Inspection Report (EIR) from US Food & Drug Administration (USFDA). The regulator had carried out the inspection at the Company's Karakhadi API Plant III in April, 2015.

Alembic Pharmaceuticals, a vertically integrated research and development pharmaceutical company, has been at the forefront of Healthcare since 1907. The company manufactures and markets generic pharmaceuticals products all over the world.

Alembic Pharma Share Price

762.65 3.65 (0.48%)
21-Apr-2026 13:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1670.60
Dr. Reddys Lab 1220.90
Cipla 1231.05
Zydus Lifesciences 927.40
Lupin 2324.30
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×